Nagai, H., Ikematsu, H., Tenjinbaru, K., Maeda, A., Dramé, M., & Roman, F. P. (2010). A phase II, open-label, multicentre study to evaluate the immunogenicity and safety of an adjuvanted prepandemic (H5N1) influenza vaccine in healthy Japanese adults. BioMed Central.
Citação norma ChicagoNagai, Hideaki, Hideyuki Ikematsu, Kazuyoshi Tenjinbaru, Atsushi Maeda, Mamadou Dramé, and François P. Roman. A Phase II, Open-label, Multicentre Study to Evaluate the Immunogenicity and Safety of an Adjuvanted Prepandemic (H5N1) Influenza Vaccine in Healthy Japanese Adults. BioMed Central, 2010.
ציטוט MLANagai, Hideaki, et al. A Phase II, Open-label, Multicentre Study to Evaluate the Immunogenicity and Safety of an Adjuvanted Prepandemic (H5N1) Influenza Vaccine in Healthy Japanese Adults. BioMed Central, 2010.